Amgen, Genentech cutting some staff (via Endpoints News's Brittany Meiling)
Two biotech giants — Amgen and Genentech — are laying off a combined 330 people at California facilities, both citing “organizational changes” as the primary reason for the cuts.
Amgen is shaking up its R&D department, eliminating 200 positions at its Thousand Oaks, CA and South San Francisco facilities by the end of this year, STAT reported Saturday. An Amgen spokesperson tells me the company is making organizational changes across the globe in regards to its R&D departments. This round of layoffs, however, mostly impacts facilities in California....
...For Genentech, the layoffs are concentrated at its Vacaville, CA manufacturing facility, where about 1,000 people are employed. Genentech (owned by Roche) is cutting 130 positions....
Also, in the news in Indianapolis (via WBOI's Annie Ropeik):
At Indianapolis-based pharmaceutical giant Eli Lilly, 2,300 employees will take buyouts as part of the company’s effort to save money by cutting at least 2,000 jobs in the U.S. by the end of the year.
It’s unclear whether layoffs are still in the works in the Hoosier state.
Lilly said in September it would aim to save $500 million by cutting 3,500 jobs out of its more than 41,000 worldwide, with at least 2,000 cut in the U.S....Best wishes to those affected.
Hiç yorum yok:
Yorum Gönder